InsiderTrades

Form 4 for ALXO ALX ONCOLOGY HOLDINGS INC

Accepted 2023-06-13 00:00:00 ET · period of report 2023-06-09 · accession 0001209191-23-036733 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-06-13 2023-06-09 ALXO Randolph Sophia Chief Medical Off, Dir M - OptEx $3.75 +12.8K 276.8K +5% +$48.2K
DM 2023-06-13 2023-06-09 ALXO Randolph Sophia Chief Medical Off, Dir M - OptEx $0.00 -12.8K 92.6K -12% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-06-09 M A 4,027 $1.91 274,280 D — —
2 Common Common Stock 2023-06-09 M A 6,256 $4.81 283,082 D — —
3 Common Common Stock 2023-06-09 M A 2,546 $4.08 276,826 D — —
4 Derivative Employee Stock Option (right to buy) 2023-06-09 M D 4,027 $0.00 0 D $1.91 · — to 2029-09-12 4,027 Common Stock (F1) The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on June 16, 2019.
5 Derivative Employee Stock Option (right to buy) 2023-06-09 M D 6,256 $0.00 19,084 D $4.81 · — to 2030-04-27 6,256 Common Stock (F3) Shares subject to the option vest in 48 equal monthly installments beginning on May 27, 2020.
6 Derivative Employee Stock Option (right to buy) 2023-06-09 M D 2,546 $0.00 92,629 D $4.08 · — to 2030-03-09 2,546 Common Stock (F2) The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on April 9, 2020.